Lista de obras - Gina Gualano - Dominio Público Uruguay

Active Tuberculosis Case Finding Interventions Among Immigrants, Refugees and Asylum Seekers in Italy.

artículo científico publicado en 2016

Assessment of CD27 expression as a tool for active and latent tuberculosis diagnosis

artículo científico publicado en 2015

Beyond multidrug-resistant tuberculosis in Europe: a TBNET study.

artículo científico publicado en 2015

Burden and Characteristics of the Comorbidity Tuberculosis-Diabetes in Europe: TBnet Prevalence Survey and Case-Control Study

artículo científico publicado en 2018

Clinical Management of Multidrug-resistant Tuberculosis in 16 European Countries.

artículo científico publicado en 2018

Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.

artículo científico publicado en 2016

ERS/ECDC Statement: European Union Standards for Tuberculosis Care - 2017 update.

artículo científico publicado en 2018

Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis

artículo científico publicado en 2016

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.

artículo científico publicado en 2017

Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.

artículo científico publicado en 2016

Faster for less: the new "shorter" regimen for multidrug-resistant tuberculosis

artículo científico publicado en 2016

IFNγ/TNFα specific-cells and effector memory phenotype associate with active tuberculosis

artículo científico publicado en 2013

Improved detection of human influenza A and B viruses in respiratory tract specimens by hemi-nested PCR.

artículo científico

Modulation of CD4 and CD8 response to QuantiFERON-TB Plus in patients with active tuberculosis and latent tuberculosis infection followed over time during treatment

artículo científico publicado en 2016

Multidrug-Resistant Tuberculosis In A Referral Center In Rome: 2011- 2016

artículo científico publicado en 2019

Multidrug-resistant tuberculosis in Europe, 2010-2011

artículo científico publicado en 2015

New Antituberculosis Drugs: From Clinical Trial to Programmatic Use

artículo científico publicado en 2016

Phylogenetic analysis of human coronavirus NL63 circulating in Italy

article

Putting in harm to cure: Drug related adverse events do not affect outcome of patients receiving treatment for multidrug-resistant Tuberculosis. Experience from a tertiary hospital in Italy

article

Safety and tolerability of clarithromycin in the treatment of multidrug-resistant tuberculosis

artículo científico publicado en 2017

Socioeconomic status and biomedical risk factors in migrants and native tuberculosis patients in Italy.

artículo científico publicado en 2017

The diabetes-tuberculosis co-epidemic: the role of international migration.

artículo científico publicado en 2016

Treatment Outcomes in Multidrug-Resistant Tuberculosis.

artículo científico publicado en 2016

Treatment outcomes of MDR-TB and HIV co-infection in Europe

artículo científico publicado en 2017

Tuberculin skin test - Outdated or still useful for Latent TB infection screening?

scientific article published on 06 February 2019

Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not Cure.

artículo científico publicado en 2017

Tuberculosis case finding based on symptom screening among immigrants, refugees and asylum seekers in Rome

artículo científico publicado en 2013

Use of several immunological markers to model the probability of active tuberculosis

artículo científico publicado en 2016

World Tuberculosis Day March 24th 2019 Theme: "It's TIME" - International Journal of Infectious Diseases Tuberculosis Theme Series

artículo científico publicado en 2019

[An integrated model for the evaluation and risk management of tuberculosis infection and active tuberculosis in homeless people in the city of Rome (Italy)]

artículo científico publicado en 2008

Lista de obras de Gina Gualano

Active Tuberculosis Case Finding Interventions Among Immigrants, Refugees and Asylum Seekers in Italy.

Assessment of CD27 expression as a tool for active and latent tuberculosis diagnosis

Beyond multidrug-resistant tuberculosis in Europe: a TBNET study.

Burden and Characteristics of the Comorbidity Tuberculosis-Diabetes in Europe: TBnet Prevalence Survey and Case-Control Study

Clinical Management of Multidrug-resistant Tuberculosis in 16 European Countries.

Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.

ERS/ECDC Statement: European Union Standards for Tuberculosis Care - 2017 update.

Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.

Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.

Faster for less: the new "shorter" regimen for multidrug-resistant tuberculosis

IFNγ/TNFα specific-cells and effector memory phenotype associate with active tuberculosis

Improved detection of human influenza A and B viruses in respiratory tract specimens by hemi-nested PCR.

Modulation of CD4 and CD8 response to QuantiFERON-TB Plus in patients with active tuberculosis and latent tuberculosis infection followed over time during treatment

Multidrug-Resistant Tuberculosis In A Referral Center In Rome: 2011- 2016

Multidrug-resistant tuberculosis in Europe, 2010-2011

New Antituberculosis Drugs: From Clinical Trial to Programmatic Use

Phylogenetic analysis of human coronavirus NL63 circulating in Italy

Putting in harm to cure: Drug related adverse events do not affect outcome of patients receiving treatment for multidrug-resistant Tuberculosis. Experience from a tertiary hospital in Italy

Safety and tolerability of clarithromycin in the treatment of multidrug-resistant tuberculosis

Socioeconomic status and biomedical risk factors in migrants and native tuberculosis patients in Italy.

The diabetes-tuberculosis co-epidemic: the role of international migration.

Treatment Outcomes in Multidrug-Resistant Tuberculosis.

Treatment outcomes of MDR-TB and HIV co-infection in Europe

Tuberculin skin test - Outdated or still useful for Latent TB infection screening?

Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not Cure.

Tuberculosis case finding based on symptom screening among immigrants, refugees and asylum seekers in Rome

Use of several immunological markers to model the probability of active tuberculosis

World Tuberculosis Day March 24th 2019 Theme: "It's TIME" - International Journal of Infectious Diseases Tuberculosis Theme Series

[An integrated model for the evaluation and risk management of tuberculosis infection and active tuberculosis in homeless people in the city of Rome (Italy)]